Medical Therapy for Glaucoma: Alpha-Agonists
A Patient’s Guide to Glaucoma Medications Alpha-Agonists Medication for Glaucoma About this class and how it works: Alpha-agonists have their effect on the ciliary body to reduce production of aqueous fluid. Additionally, like the prostaglandin analogs,...Medical Therapy for Glaucoma: Beta-blockers
A Patient’s Guide to Glaucoma Medications Beta-blockers for Glaucoma The Beta-blocker class of medications has been used for over half a century. Indeed, all the way up through the turn of the millenium this class was the most commonly prescribed glaucoma medication....What’s Exciting About Bimatoprost SR Glaucoma Drug Implant
Video Transcript: One of the challenges of treating glaucoma is that for most people, it’s a condition without notable symptoms. What this means is that the treatment is often more bothersome than the condition itself (at least early on in the disease). Take for...FDA Approves Preservative-Free Xelpros™ for Open-Angle Glaucoma
FDA Approves preservative-free XELPROS™ (latanoprost ophthalmic emulsion 0.005%) for intraocular pressure (IOP) reduction in patients with open-angle glaucoma and ocular hypertension
PolyActiva Commences Clinical Trial of Biodegradable Ocular Implant for Glaucoma
Clinical Trial Begins For PolyActiva Biodegradable Glaucoma Implant. PolyActiva Pty Ltd, a clinical-stage Australian biotechnology company, has recently received USD$12million in venture capital to fund its Phase 1 Clinical Trial which will evaluate the safety and tolerability of its PA5108 ocular implant designed to biodegrade after the treatment period.